Video & Transcript : 'pharmacy compounding' :

Page 54 of 218
CA

California 2025-2026 Regular Session

Assembly Health Committee Mar 17th, 2026

Transcript Highlights:
  • communities, communities that are struggling every day just to access basic, in-person, medical and pharmacy
  • In my professional role, I oversee medication therapy and clinical pharmacy services that are deeply
  • Even modest grant opportunities like this in AB 1671 can be the difference between a medical or pharmacy
  • service staying open or closing, or between a provider choosing to stay in the Pharmacy service staying
  • As someone who helps to manage clinical and pharmacy services at a system level and who experiences rural
Summary: The Assembly Health Committee met on March 17 and first approved a consent calendar of several bills, then heard AB 1540 by Assemblymember Mark Gonzalez, which would restore the 988 “Press 3” LGBTQ youth crisis line. Supporters, including suicide prevention advocates, behavioral health groups, and local governments, argued the service is a vital, identity-affirming suicide prevention tool for LGBTQ youth. Opponents, including detransitioners and conservative advocacy groups, argued it would steer vulnerable youth toward organizations they viewed as harmful. The committee approved the bill on a due-pass-as-amended motion to the Communications and Conveyance Committee, with several no votes; the bill was later held on call and then advanced. The committee next heard AB 1671 by Assemblymember Tangipa, creating a Rural Medical Provider Grant Program to help providers serving rural communities with operational costs, equipment, workforce needs, and related expenses. Supporters said the bill would help retain providers and improve access in areas where patients travel long distances for care; committee members also discussed telehealth as an important rural access tool. The bill passed on a due-pass-as-amended motion to Appropriations. The committee then took up AB 1876 by Assemblymember Addis, the Fair Care for All Act, which would codify federal health care nondiscrimination protections into California law, including protections related to race, color, national origin, age, disability, sex, and gender identity. Supporters said the bill is needed because federal protections are vulnerable to rollback and because patients, especially transgender and intersex Californians, face coverage denials and care disruptions. Opponents argued the bill would force coverage of gender-affirming care and raised concerns about detransitioning. The committee approved the bill on a due-pass motion to Judiciary, with some no votes, and later held it on call before it advanced. Finally, the committee heard AB 1629 by Assemblymember Haney, which would require dental plans to honor assignment-of-benefits requests and improve reporting on network adequacy. Supporters said the bill would reduce upfront costs for patients and improve transparency, while opponents, including Delta Dental and dental plan groups, warned it could weaken networks and increase out-of-pocket costs. After discussion about network participation and patient access, the committee passed the bill on a due-pass motion to Appropriations. The committee then completed the remaining votes, including the consent items, and adjourned.
NM
Transcript Highlights:
  • But OSI said, you know, our PBMs, our pharmacy benefit managers, and the IBAC should also do that.
  • Moving on, A pharmacy benefit manager was written in several places to clarify.
  • The three-year period is put in because if you go to the pharmacy, you’ll find that the pharmacist is
  • And also, as you may find when you go to the pharmacy, it is a definite convenience for them.
  • The Retiree Health Care Authority notes that there’s between $1.8 million and $2.6 million in pharmacy
Summary: The committee first heard SB 20, as amended, which would limit prior authorization for certain medications used to treat serious mental illness and extend prior authorization approvals for other chronic maintenance drugs to three years. The sponsor and supporters said the bill would reduce treatment interruptions and administrative burden for patients, clinicians, and pharmacies, while opponents argued the three-year period could raise safety concerns, reduce annual clinical review, and increase costs and premiums. After public testimony and committee discussion, the bill passed on a 7-2 vote. The committee then considered SB 21, as amended, establishing an annual Medigap open enrollment period with guaranteed issue protections for eligible Medicare beneficiaries already enrolled in Medigap plans. The Aging and Long-Term Services Department said the measure would give seniors more flexibility to change plans as their needs and premiums change, and OSI said premium impacts were expected to be limited. An amendment setting the effective date at January 1, 2027 was adopted, and the bill passed unanimously. Next, the committee heard SB 177, a large economic development package centered on quantum, advanced energy, defense, and related workforce and research investments. The sponsor and administration witnesses described New Mexico as uniquely positioned to attract major private and federal investment, while members raised questions about guardrails, reporting, use of the Research and Development Fund, and whether EDD could manage the spending and educational components. An amendment removed the public safety section, a technical title fix was adopted, and the bill passed 9-1. The committee also took up SB 189, which would protect existing coverage and expand insurance coverage for reproductive and gender-affirming care, including mid-year enrollment options for pregnancy and coverage for double electric breast pumps. Supporters said the bill would prevent abrupt coverage changes and ensure access to care, while opponents objected to abortion-related coverage and argued existing law and Medicaid already cover much of the care. A motion to table failed, and the bill then passed 6-4. Finally, the committee unanimously passed Senate Memorial 6 honoring golfer Nancy Lopez and her New Mexico roots and achievements.
FL

Florida 2026 4th Special Session

January 20, 2026 - 09:30 AM

Transcript Highlights:
  • Also, this is strange, Representative Bartleman: but only because my sister is a pharmacy technologist
  • that I am cognizant of this, but how this impacts pharmacists and pharmacy is - the bill's sponsor spoke
  • That is crazy to do and it puts an undue burden on pharmacies and pharmacy technicians.
  • forward to protect the mental health services for individuals, and I don't know how you figure out the pharmacy
NM

New Mexico 2025 Regular Session

Senate - Health and Public Affairs Oct 1st, 2025

Senate Health & Public Affairs

Transcript Highlights:
  • 29th of August, the New Mexico Department of Health issued a public health order in response to. pharmacies
  • here in New In August, on August 29, the Department of Health worked with the New Mexico Board of Pharmacy
  • Also, the Department of Health issued a standing order for pharmacies to administer the vaccine.
TX
Transcript Highlights:
  • I'm an independent pharmacist with Tarrytown Pharmacy here in Austin.
  • I'm with the Texas Pharmacy Association, and on behalf of myself, I'm in support of the bill.
  • My committee director says she loves your pharmacy. Yeah, you're perfect.
Bills: HB50
TX

Texas 89th Regular

Senate Session (Part I) May 8th, 2025

Texas Senate Floor Meeting

Transcript Highlights:
  • Also, the program with the Department of Health and Human Services simplifies eligibility for pharmacy
  • participation, removes the cap on the number of participating pharmacies, allows over-the-counter prescription
  • drugs to be collected, and streamlines the application process for pharmacies with multiple locations
Bills: HJR98, HJR99, HB29, HB136, HB142, HB166, HB353, HB1399, HB2000, SJR59, SCR19, SB128, SB261, SB317, SB383, SB393, SB397, SB466, SB517, SB571, SB612, SB705, SB715, SB731, SB748, SB801, SB867, SB913, SB945, SB946, SB986, SB1013, SB1071, SB1086, SB1087, SB1117, SB1181, SB1250, SB1263, SB1285, SB1444, SB1483, SB1528, SB1553, SB1556, SB1608, SB1723, SB1858, SB1946, SB1957, SB1986, SB1999, SB2043, SB2056, SB2082, SB2105, SB2133, SB2138, SB2177, SB2203, SB2221, SB2311, SB2334, SB2337, SB2340, SB2373, SB2417, SB2446, SB2452, SB2477, SB2532, SB2565, SB2587, SB2615, SB2622, SB2633, SB2637, SB2681, SB2713, SB2717, SB2781, SB2782, SB2835, SB2841, SB2857, SB2891, SB2943, SB2994, SB2995, SB3016, SB3047, SB3057, SB3059, SJR3, SB5, SB72, SB509, SB616, SB963, SB985, SB1143, SB1172, SB1267, SB1271, SB1273, SB1759, SB1786, SB2361, SB1025, SB1080, SB1245, SB1355, SB1422, SB1, SB260, SB1506, SB1637, HJR98, HJR99, HJR2, HJR1, HB1109, HB1392, HB22, HB3093, HB517, HB1130, HB142, HB1689, HB2018, HB136, HB2884, HB1393, HB2730, HB1399, HB1244, HB467, HB331, HB2559, HB29, HB26, HB166, HB353, HB2000, HB2756, HB3248, HB3513, HB3204, HB3135, HB3012, HB2763, HB2523, HB2457, HB2415, HB2198, HB2143, HB1708, HB1672, HB767, HB1327, HB2723, HB451, HB140, HB109, HB3096, HCR6, HCR12, HCR29, HCR50, HCR55, HCR56, HCR58, HCR70, HCR71, HCR74, HCR78, HCR80, HCR107, HCR116, HCR117, SJR36, SJR50, SJR63, SJR59, SCR12, SCR39, SCR48, SCR19, SB2023, SB1957, SB2615, SB2138, SB3016, SB1999, SB62, SB666, SB847, SB284, SB854, SB1073, SB810, SB1505, SB583, SB507, SB1434, SB1772, SB2016, SB1163, SB1122, SB731, SB397, SB508, SB1436, SB287, SB261, SB1882, SB393, SB1791, SB209, SB2429, SB511, SB2309, SB510, SB1085, SB1975, SB2717, SB1262, SB636, SB2056, SB884, SB517, SB1200, SB1845, SB2681, SB2458, SB801, SB3014, SB3013, SB758, SB1013, SB2797, SB2076, SB2876, SB715, SB1640, SB2538, SB1449, SB1181, SB1359, SB410, SB1234, SB2926, SB2972, SB2841, SB1856, SB1528, SB1373, SB672, SB2891, SB1854, SB317, SB2539, SB2532, SB1250, SB2082, SB2203, SB1285, SB1454, SB2520, SB1237, SB1586, SB2819, SB629, SB2342, SB2903, SB2477, SB3029, SB375, SB777, SB2367, SB2703, SB2608, SB2965, SB2521, SB2165, SB2501, SB2452, SB2835, SB1602, SB1704, SB1723, SB1858, SB1946, SB2009, SB2177, SB2460, SB2785, SB2373, SB867, SB1608, SB640, SB1698, SB383, SB705, SB748, SB1117, SB2340, SB2680, SB2994, SB2747, SB1950, SB913, SB1071, SB1086, SB1087, SB1483, SB1444, SB1553, SB1556, SB1703, SB2133, SB2297, SB2298, SB2622, SB2955, SB3059, SB2782, SB2781, SB2637, SB2633, SB2337, SB2334, SB1861, SB2043, SB1367, SB946, SB945, SB2857, SB128, SB571, SB1263, SB3058, SB612, SB2221, SB2587, SB2044, SB2363, SB2713, SB2311, SB1986, SB2565, SB2943, SB1888, SB2417, SB3048, SB3052, SB3053, SB3036, SB3057, SB3056, SB3043, SB3037, SB3050, SB3063, SB3047, SB3035, SB2446, SB466, SB2611, SB2794, SB2105, SB2017, SB1790, SB1778, SB1730, SB2995, SB2847, SB205, SB2619, SB1903, SB203, SB3061, SB1581, SB2600, SB2799, SB2790, SB2688, SB2515, SB1230, SB876, SB2522, SB2639, SB2137, SB2519, SB2403, SB2459, SB3051, SB2655, SB2251, SB2764, SB2878, SB1884, SB111, SB582, SB2617, SB1835, SB2751, SB2959, HB206, HB1238, HB1089, HB2890, HB9, HB2081, HB4215, HB2970, SB2063, SB1400, SB2058, SB2260, SB2928, SB1310
ND

North Dakota 2025-2026 Regular Session

Health Care Committee Jul 15th, 2026

Transcript Highlights:
  • There are save laws in the states that providers, pharmacies, etc., cannot be prosecuted for sending
  • Why don't you take both to the pharmacy and see what happens?
  • They get to the pharmacy, unfortunately, some sort of a PA or a unique criteria that requires failure
  • Why don't you take both to the pharmacy see what happens?
  • They get to the pharmacy, unfortunately, some sort of a PA or a unique criteria that requires failure
Summary: The committee first approved the previous meeting minutes and then heard a detailed annual report from Dr. Thomas Arnold, chair of the Maternal Mortality Review Committee, on maternal mortality trends and policy issues. He explained the committee’s review process, confidentiality protections, and national and North Dakota data showing that most maternal deaths are preventable and that mental health conditions, substance use, cardiovascular issues, infection, hemorrhage, and embolism are the leading causes. Members asked about suicide, domestic violence, midwife training, home births, and whether pregnancy testing at death scenes should be expanded; Dr. Arnold said better coroner education, more investigation of unexplained deaths, and possible post-mortem pregnancy testing could improve case identification, especially in rural areas. He also noted that deaths often occur well after 42 days postpartum and that mental health-related deaths remain a major concern. The committee then heard from State Fire Marshal Dr. Matthew Clark on cigarette reduced-ignition-propensity standards and related fire prevention issues. He recommended updating the state’s cigarette propensity law to current national standards and also raised a separate recommendation to require fast-breakaway oxygen tubing for home oxygen users, citing fatal fires linked to smoking around oxygen. Members asked about implementation, cost, insurance coverage, and whether the standards apply in tribal communities; Dr. Clark said he would provide follow-up information and was willing to help with any legislation, but no agency bill had yet been planned. Next, Christine Greff of the Department of Health and Human Services reported on the North Dakota Stroke System of Care. She described the statewide network of stroke-ready hospitals, registry-based quality improvement, and performance data showing continued improvement in stroke recognition, imaging, thrombolytic treatment, transfers, and EMS pre-notification. She highlighted new quality measures for inter-facility transfers and intracerebral hemorrhage care, and said the system remains strong but depends on continued legislative and hospital support. Committee members asked about participation by the VA hospital and were encouraged to consider outreach to include it more fully in the stroke system. Finally, the committee began a presentation on prior authorization and non-opioid pain treatment from Taha Khan of Vertex Pharmaceuticals. He argued that prior authorization can delay access to non-opioid acute pain medications, especially in the 24- to 72-hour post-discharge window when pain is most severe, and said delays can push patients toward opioids. He emphasized that prior authorization has a role in utilization management but should not create barriers in acute pain care, and he noted that current use of the company’s non-opioid product remains very low. The discussion was still underway when the transcript ended.
MN

Minnesota 2025-2026 Regular Session

Committee on Finance - 05/06/26

Finance

Transcript Highlights:
  • Chair, no, I don't remember any engagement with the Board of Pharmacy.
  • </c> pharmacy as well. pharmacy as well.
  • </c><01:14:57.040><c> I</c> engagement with the board of pharmacy.
  • I engagement with the board of pharmacy.
  • </c> uh board of pharmacy etc. uh board of pharmacy etc.
Keywords: 1187, senate, all
NH

New Hampshire 2026 Regular Session

Senate Health and Human Services (03/04/2026)

Health and Human Services

Transcript Highlights:
  • </c><00:18:56.080><c> benefit</c><00:18:56.480><c> manager</c> transparency in pharmacy benefit manager
  • transparency in pharmacy benefit manager practices<00:18:58.000><c> in</c><00:18:58.240><c> the</c><
  • So, this has been the year of pharmacy benefit managers and pharmacy management legislation.
  • Uh, and long before anyone even knew what a pharmacy benefit manager was.
  • </c><01:35:09.199><c> benefits</c> Hampshire as a pharmacy benefits Hampshire as a pharmacy benefits
Keywords: 1191, senate, all
MS

Mississippi 2026 Regular Session

MS Senate Floor - 19 February, 2026; 10:00 AM

Mississippi Senate Floor Meeting

Transcript Highlights:
  • Uh Senate Bill 3075, appropriation<01:10:09.320><c> Pharmacy</c><01:10:09.760><c> Board.
  • Then the Board of Pharmacy is quite a bit over LBR.
  • Then the Board<01:11:12.240><c> of</c><01:11:12.320><c> Pharmacy</c> Board of Pharmacy Board of Pharmacy
  • </c><01:11:37.080><c> has</c> that the Board of Pharmacy has that the Board of Pharmacy has established
  • I think that is something to do with auditing the pharmacy reporting system, the PMP.
CA

California 2025-2026 Regular Session

Senate Health Committee Feb 18th, 2026

Transcript Highlights:
  • chemistry, toxicology, and health risk of botanical products, including kratom and kratom-derived compounds
  • What is important to understand is that these two compounds, mitragynine and 7-OH, are not really equal
  • Second, one kratom-related compound, specifically 7-OH, behaves much more like traditional opioids than
  • spread of products that concentrate Spread and uncontrolled spread of products that concentrate this compound
  • and potential of the kratom alkaloid 7-OH, which is an analgesic, anti-inflammatory, antioxidant compound
Summary: The committee held an informational hearing on kratom and 7-hydroxymitragynine (7-OH), focusing on public health risks, overdose deaths, and regulatory gaps in California. The chair opened by noting that FDA and CDPH consider kratom and 7-OH products unlawful, yet they remain widely sold in smoke shops, vape stores, gas stations, and convenience stores. Members referenced AB 1088, which would be considered later, and said the hearing was intended to clarify the science, medical perspective, and whether stronger safeguards are needed. The first panel featured a toxicology expert, state and local public health officials, an emergency/addiction physician, a medical examiner, and county health representatives. Witnesses from CDPH and Los Angeles County described rising deaths and enforcement actions, including statewide advisories, retailer letters, and product removals from manufacturers, wholesalers, and retailers. Medical testimony emphasized that 7-OH acts much more like an opioid than traditional kratom leaf, can cause dependence, withdrawal, and respiratory depression, and may require naloxone, buprenorphine, or methadone in overdose or withdrawal cases. Local officials said enforcement is difficult because packaging is inconsistent, testing capacity is limited, and counties lack resources and statewide infrastructure; they generally favored a centralized state framework if regulation is pursued. Committee members asked about testing, age restrictions, scheduling, and whether a distinction between kratom and 7-OH could be enforced. Witnesses said forensic labs can potentially test for 7-OH but validated assays are not routine, emergency departments cannot readily distinguish exposures, and local health departments do not have the lab capacity to verify product labels. Several officials warned that a ban or abrupt scheduling could push products into the black market and discourage research, while others argued that current prohibition and enforcement are the most protective approach because legalization or age-limited regulation could create confusion about legality and safety. The second panel included kratom and 7-OH advocates and industry representatives, who argued that natural kratom leaf and concentrated or synthetic 7-OH are different products and should be regulated differently. They supported age-gating, labeling, testing, and packaging rules for kratom leaf while opposing a ban on the botanical. They said 7-OH is used by many adults for pain relief or harm reduction, and that prohibition would drive consumers to illicit markets and worsen harm. Committee members pressed them on whether 7-OH is more potent than kratom, the availability of testing, and whether any safe dose is known. The hearing ended without a vote or formal action, with the chair noting the issue will continue to be considered in future legislation.
LA

Louisiana 2026 Regular Session

Senate May 19th, 2026

Louisiana Senate Floor Meeting

Transcript Highlights:
  • It's an act to amend Title 22 relative to pharmacy benefit managers, to provide for definitions and to
  • provide for pharmacy reimbursements.
  • HB 1236 has to do with the dispensing fee for local pharmacies.
  • It does make the dispensing fee retroactive, but it does so back to January 1 for local pharmacies.
  • It does make the dispensing fee retroactive, but it does so back to January 1 for local pharmacies.
Bills: SR126, SR129, SCR71, SCR72, SCR73, SCR12, HB221, HCR54, HCR79, HCR87, HCR94, HCR95, HCR97, HCR102, HCR104, HCR58, SB480, SB514, HB12, HB66, HB145, HB167, HB175, HB196, HB213, HB218, HB222, HB256, HB291, HB325, HB326, HB352, HB401, HB430, HB433, HB434, HB448, HB456, HB476, HB481, HB487, HB492, HB549, HB579, HB608, HB621, HB624, HB626, HB632, HB637, HB656, HB722, HB745, HB749, HB804, HB818, HB821, HB833, HB864, HB867, HB874, HB893, HB909, HB951, HB968, HB969, HB978, HB979, HB985, HB988, HB989, HB1001, HB1005, HB1007, HB1024, HB1032, HB1038, HB1050, HB1051, HB1056, HB1059, HB1077, HB1080, HB1081, HB1086, HB1108, HB1112, HB1153, HB1172, HB1173, HB1175, HB1192, HB1193, HB1204, HB1218, HB1242, HB1244, HB1249, HB1252, HB1254, HB538, SCR3, SCR23, SCR38, SCR24, SB102, SB133, SB151, SB165, SB169, SB170, SB200, SB217, SB280, SB291, SB300, SB303, SB330, SB449, SB489, SB521, SB45, SB156, SB181, SB203, SB274, SB304, SB379, SB396, SB410, SB425, SB427, SB436, SB54, SB72, SB129, SB164, SB232, SB287, SB322, SB374, SB375, SB386, SB409, SB447, SB458, SB222, SB399, SR119, SCR58, SCR65, SCR9, SB35, SB65, SB215, SB246, SB249, SB269, SB282, SB296, SB323, SB363, SB369, SB474, SB490, SB492, SB500, HCR41, HCR47, HCR63, HCR69, HCR31, HB87, HB115, HB162, HB195, HB214, HB217, HB233, HB283, HB290, HB319, HB324, HB345, HB362, HB363, HB368, HB377, HB380, HB382, HB386, HB392, HB406, HB431, HB441, HB466, HB503, HB533, HB559, HB575, HB590, HB593, HB618, HB655, HB664, HB685, HB692, HB707, HB715, HB732, HB738, HB741, HB748, HB776, HB807, HB822, HB856, HB860, HB868, HB887, HB888, HB905, HB908, HB961, HB980, HB990, HB992, HB999, HB1000, HB1010, HB1146, HB1157, HB1233, HB1236, HB1243, HB54, HB137, HB180, HB192, HB310, HB321, HB396, HB512, HB552, HB578, HB638, HB663, HB708, HB717, HB718, HB1009, HB1082, HB1104, HB1107, HB1198, HB1246, HB27, HB143, HB205, HB259, HB267, HB288, HB308, HB403, HB405, HB414, HB417, HB478, HB546, HB548, HB555, HB557, HB609, HB670, HB672, HB740, HB779, HB786, HB796, HB812, HB848, HB915, HB917, HB921, HB930, HB933, HB1095, HB1096, HB1103, HB1129, HB1154, HB1166, HB1187, HB1195, HB1230, HB17, HB36, HB41, HB47, HB73, HB119, HB126, HB129, HB133, HB140, HB159, HB166, HB211, HB226, HB245, HB271, HB280, HB337, HB351, HB354, HB399, HB571, HB677, HB712, HB723, HB726, HB728, HB750, HB759, HB789, HB844, HB850, HB870, HB966, HB1006, HB1018, HB1036, HB1241, SB29, SB42, SB43, SB382, SB441, HB134, HB258, HB359, HB782
Summary: The Senate convened with a quorum, heard a prayer from guest minister Troy Brigadio, and recited the pledge. The chamber then handled journal approval, committee and House messages, and a large number of resolutions and bills, with many items lying over or being referred to committees. Several Senate resolutions were adopted by voice or machine vote, including commendations for World Preeclampsia Awareness Day, Kathy Holloway, Jensen LeBlanc, and River Bend Station, and the Senate also recognized Senator Mike Reese’s new role as president of McNeese State University. The body spent much of the meeting concurring in or rejecting House amendments to Senate bills. Concurrences were approved on measures including SB 102, 133, 151, 165, 169, 170, 200, 280, 291, 303, 330, 396, 410, 425, 427, 436, 489, 521, 45, 156, 181, 203, 304, and 399. The Senate rejected House amendments on SB 217, SB 300, SB 274, and SB 379, sending those matters toward conference or further work. One notable floor debate occurred on SB 449, where Senator Moore objected to concurring in amendments affecting the North Orleans Belt Railroad; after discussion about corruption concerns and public bid laws, the chamber rejected the amendments 26-9. The Senate also took up numerous House bills on final passage, approving measures on local governance, public safety, education, tax policy, and infrastructure. These included HB 87 on Livingston Parish Gas Utility District per diem, HB 115 on abolishing the police chief office in Edgefield, HB 162 on a neighborhood improvement district fee, HB 195 allowing pepper spray on campus, HB 214 and HB 217 on optional ad valorem tax exemptions for rehabilitated blighted property, HB 233 on jury compensation, HB 354 renaming a bridge as the Caleb Easterling Memorial Bridge, HB 283 on protections for assaulted school employees, HB 290 recreating the Department of Treasury, and HB 319 adjusting civic education commission membership. Several of these passed unanimously or with only a few dissenting votes, and members frequently moved to reconsider and record objections after final passage.
MO

Missouri 2026 Regular Session

2026 Legislative Session - Day Fifty - Monday, April 13

Missouri House Floor Meeting

Transcript Highlights:
  • House Bill 3009 provides clear statutory guidance for pharmacies in Missouri, pharmacies that serve low-income
  • So they would get their medications from a different pharmacy? Is that? Yes.
  • I just couldn't— we've heard so many pharmacy bills.
  • Speaker, this is a good bill, especially in cases of emergency when we need nonprofit pharmacies to come
  • their medication when there's chaos and they don't know whether they can't get to their regular pharmacy
Summary: The House opened with prayer, the Pledge of Allegiance, and approval of the previous day’s journal by roll call vote, 127-2. Members then used points of personal privilege and guest introductions to recognize a new grandchild, President Thomas Jefferson’s birthday, Artemis II and Missouri’s role in space manufacturing, Line Worker Appreciation Day, a visiting mayor, and a former representative. The chamber then moved into third reading and perfection business. Several bills were passed. House Committee Substitute for House Bill 2740, creating a pediatric disease task force in the Department of Higher Education and Workforce Development, passed 139-1 after supporters described it as a limited, accountable way to coordinate research and report on outcomes. House Bill 2422, which raises a county filing fee to support the Department of Agriculture’s Land Survey Program, passed 131-6 after members said the program could not continue on the current fee. House Committee Substitute for House Bill 311, moving bail bond oversight under the Board of Private Investigators and Fire Investigators, passed 112-22. House Committee Substitute for House Bill 3009, allowing nonprofit pharmacies to provide medications during emergencies, passed 133-6. House Committee Substitute for House Bill 2474, authorizing progressive design-build project delivery for public construction, and House Committee Substitute for House Bill 3076, clarifying that common agricultural practices are exempt from non-point source permitting under clean water law, were both ordered perfected and printed. House Joint Resolution 159, which would modernize the state treasurer’s constitutional investment authority, drew the most debate. The sponsor argued it would update outdated restrictions, allow safer investment options, and generate an estimated $15.1 million without raising taxes. An amendment adding legislative, governor, and auditor approval for changes to the investment policy was adopted. Supporters called the proposal conservative and bipartisan, while opponents warned the language was too broad and could reopen questions about risky investments or conflict-of-interest issues. After debate, the House adopted the committee substitute and ordered the resolution perfected and printed. The chamber also took up House Bill 2436, dealing with animal impoundment, return of animals when no charges are filed or a defendant is found innocent, and related animal neglect provisions. Members adopted a title amendment, then adopted an amendment creating penalties for malicious false reports of animal abuse and another amendment modernizing neglect and abandonment offenses, including provisions on adequate care and control and higher penalties for repeat or harmful conduct. Debate centered on whether the bill was necessary, how to define malicious reporting, and concerns from animal welfare groups versus law enforcement and agricultural interests. The bill remained under consideration as the transcript ended.
MO

Missouri 2026 Regular Session

2026 Legislative Session - Day Forty Five - Wednesday, April 1 - Morning Session

Missouri House Floor Meeting

Transcript Highlights:
  • right in the upper gallery, under education, you're going to see some great pharmacists, some great pharmacy
  • Louis College of Pharmacy, and she is from Dunklin County and went to school with my son.
  • Louis College of Pharmacy at St. Louis University studying... Thank you. our future.
  • Louis College Pharmacy at St. Louis University studying Thank you. The St.
  • Louis College of Pharmacy at St. Louis University, studying pharmacy.
Keywords: 959, house, all
Summary: The House began with prayer, the Pledge of Allegiance, approval of the House Journal by roll call vote (112-2), and numerous introductions of special guests, including former Rep. Bill Kidd, students, educators, pharmacy students, labor representatives, and community groups. Members also made a few personal announcements, including a birthday recognition. The chamber then moved into floor business on bills for perfection and printing. The main debate centered on House Committee Substitute for House Bills 21, 22, and 1626, the Missouri Nuclear Clean Power Act. Supporters argued the bill would remove Missouri’s ban on construction work in progress for nuclear plants, lower long-term electricity costs, support baseload power, attract industry and data centers, and help Missouri keep pace with small modular reactor development in other states and countries. Opponents said the measure would shift construction risk and potential cost overruns to ratepayers, cited past nuclear cost overruns and safety/waste concerns, and argued Missouri voters had already rejected this approach. After extended debate and several inquiries, the House adopted the committee substitute and then perfected and printed the bill. The House also perfected and printed House Bill 1881, which would classify xylazine as a Schedule III controlled substance. Supporters said the drug is being misused in fentanyl mixtures, causing severe harm and deaths, while preserving legitimate veterinary and agricultural uses. Members from veterinary and law enforcement backgrounds backed the bill, and no opposition was voiced before passage. Finally, the House took up House Committee Substitute for House Bill 2292, a cross-reporting bill for child, elder, and companion animal abuse. The sponsor said the measure would require agencies already involved in abuse reporting to cross-report related abuse and train accordingly, while exempting agricultural animals. Members discussed amendments to criminalize knowingly starving an animal and to allow POST-certified state investigators to assist in elder abuse cases; both amendments were adopted. Debate also focused on concerns about training sources and whether animal-rights groups could misuse the bill, but the sponsor said the measure would not expand access to farms or animal control authority. The committee substitute was advanced after discussion.
WA

Washington 2025-2026 Regular Session

House Environment & Energy Jan 15th, 2026 at 08:00 am

Environment & Energy

Transcript Highlights:
  • I've been president of Ray's Pharmacy, the only pharmacy on Orcas Island and one of three in San Juan
  • have over 500,000 visitors that come to San Juan County, and Island Market grocery store and Ray's Pharmacy
  • So I would say 80% of my customers, outside of our pharmacy customers that for HIPAA reasons have to
  • County and Island Market grocery store and raised pharmacy, two biggest businesses on the retail front
  • So I would say 80% of my customers outside of our pharmacy customers that for HIPAA reasons have to have
NH

New Hampshire 2025 Regular Session

House Health, Human Services and Elderly Affairs (04/16/2025)

Health, Human Services & Elderly Affairs

Transcript Highlights:
  • third-party data vendors, uh, is of some interest, especially if it's paralleled with the PBMs in the pharmacy
Keywords: 1189, house, all
MD

Maryland 2026 Regular Session

House Floor Session, 2/19/2026 #1

Maryland House Floor Meeting

Transcript Highlights:
  • Colleagues, today we are pleased to welcome members of the Maryland Pharmacy Coalition as they join us
  • So, please join me in recognizing the members of the Maryland Pharmacy Coalition who are with us today
  • </c><01:26:43.440><c> Coalition</c><01:26:43.920><c> as</c> of the Maryland Pharmacy Coalition as of
  • , and student pharmacy technicians, and student pharmacists<01:26:54.719><c> from</c><01:26:54.960><c
  • Coalition who are with us Pharmacy Coalition who are with us today. today. today.
KY
Transcript Highlights:
  • . >> And in pharmacy, the commissioner mentioned earlier that pharmacy, particularly the specialty and
  • Uh, the continuous need is growing for those services. >> And in pharmacy, the commissioner mentioned
  • Uh, the continuous need is growing for those services. >> And in pharmacy, the commissioner mentioned
  • ><c> commissioner</c> and in pharmacy the commissioner and in pharmacy the commissioner mentioned<00:
  • </c> mentioned earlier the pharmacy for mentioned earlier the pharmacy for particularly<00:54:45.119>
Summary: The House Budget Review Subcommittee on Health and Family Services met for an overview of the Department for Medicaid Services budget. Commissioner Lisa Lee and CFO Steve Beal described Kentucky Medicaid enrollment at about 1.4 million members, including more than 600,000 children, and said the agency’s 2025 total budget was $20.6 billion. They reviewed enrollment trends before, during, and after the COVID-19 public health emergency, noting that redeterminations begun in 2023 reduced enrollment from its peak but that total membership remains above pre-COVID levels. They also explained the difference between the fee-for-service population, which includes long-term care and waiver members, and managed care members, and gave examples of the kinds of services and diagnoses seen in each group. A major focus was the governor’s recommended Medicaid budget and the department’s forecast process. Lee said the budget is split into benefits and administration, with benefits covering fee-for-service services, managed care capitation, transportation, and Medicare premiums, while administration covers contracts, personnel, operating costs, and IT-related advanced planning documents. She said the department uses a consensus forecasting group and actuary input, and that its forecasts have been within 1% of actual spending in recent years. The department also said the governor’s budget includes new waiver slots to address waiting lists, a 2% staff COLA, and a 10% phase-down on state-directed payments beginning in January 2028. Much of the discussion centered on House Resolution 1 and the funding needed to implement its Medicaid-related provisions, including community engagement requirements, six-month redeterminations, and future cost sharing. Lee said the department requested about $35 million in total funds for fiscal 2027, including about $8.2 million in general funds for system changes to the integrated eligibility system, claims processing, notices, and monitoring; and about $11 million in fiscal 2028 for ongoing maintenance, with about $1.6 million in general funds. She said the department expects to seek federal APD matching funds for the IT work. In response to questions, she explained that community engagement would apply to Medicaid expansion members, with qualifying activities including work, school, volunteering, or equivalent income, and that certain groups such as pregnant women, children, caretaker relatives, and some people with chronic disease or substance use disorder would be excluded. She said the department identified roughly 70,000 expansion members who could be subject to the requirement. No votes or formal actions were taken.
MA

Massachusetts 2025-2026 Regular Session

Joint Committee on Public Safety and Homeland Security Jun 21st, 2026 at 01:00 pm

Joint Committee on Public Safety and Homeland Security

Transcript Highlights:
  • Compounding this threat of physical violence is this epidemic of K2, Compounding this threat of physical
  • This drug, commonly referred to as K2, is a class of synthetic chemical compounds that are often sprayed
  • we can train drug dogs to detect these substances, but because the chemical composition of these compounds
  • intersection of identities makes sex workers a uniquely vulnerable population, an inequity that is compounded
Keywords: 995, all
Summary: The committee heard testimony on a wide range of public safety bills, with strong support from law enforcement, advocates, and other stakeholders. Several measures focused on police and correctional officer wellness and protections, including bills on critical incident leave and post-incident support for officers, a bill to improve POST Commission representation, and a bill to protect correctional officers from assaults and exposure to synthetic drugs like K2. Witnesses described traumatic incidents, rising assaults in prisons, staffing shortages, and the need for confidentiality in peer-support debriefings. Committee members asked questions about assault classifications, K2 smuggling, tablet-related contraband, and whether counseling records would remain confidential. No votes were taken during the hearing. A major portion of the hearing was devoted to canine-related bills. Testimony supported creating a fund for retired police dogs and expanding emergency care training for working dogs injured in the line of duty. Speakers described police dogs as partners who locate suspects, missing persons, drugs, and weapons, and said retirement and medical costs are currently borne by handlers or nonprofits. The committee also heard testimony in favor of a purple alert system for missing people with intellectual and developmental disabilities, with advocates citing wandering risks, drowning dangers, and data from other states showing faster recovery times. The committee also heard testimony on a bill to expand the definition of sexual assault by an officer to cover situations beyond formal custody, including investigations and other encounters where police have coercive power. Advocates for sex workers and anti-trafficking organizations said the change would close a loophole, protect vulnerable people, and address documented abuses. In addition, testimony was taken on a bill to protect Massachusetts residents from federal surveillance through fusion centers, with critics calling for stronger oversight of BRIC and related databases. Representative Jeff Turco also testified on bills to change POST Commission membership, arguing for more law enforcement representation.
AZ
Transcript Highlights:
  • Madam Chair and members, House Bill 2953 prohibits the Arizona State Board of Pharmacy from issuing nondisciplinary
  • The bill also prohibits the Arizona State Board of Pharmacy from issuing any civil penalties imposed
  • I can give a brief overview, but basically the Board of Pharmacy is a little bit different than a lot
  • They not only regulate the pharmacists and the pharmacies, they also regulate pharmaceutical manufacturers
Summary: The committee approved the minutes and then heard several bills. HB 2686, sponsored by Rep. Heap, would require physicians performing surgeries at outpatient surgical facilities to annually and whenever changed provide the facility a call-coverage plan, including hospital coverage if applicable, to ensure patients have a known physician contact for complications; it passed 6-0 with one not voting. HB 2051 would require AHCCCS contractors, subject to CMS approval, to cover breastfeeding and lactation services in inpatient, outpatient, home-based, and group settings; supporters described the bill as improving maternal and infant health and AHCCCS said it was neutral with an estimated $1.8 million general fund cost, and it passed 6-0 with one not voting. HB 2837, a transparency bill for municipal zoning hearings, would require speakers to disclose compensation for testimony and require certain board members or hearing officers to disclose and recuse for recent ties to entities appearing before them; it passed 6-0 with one not voting. The committee also approved HB 2875, as amended, which clarifies local authority over commercial drone delivery systems and related land-use and zoning issues, including near airports; Zipline and industry supporters backed the bill as providing regulatory clarity, and it passed 6-0 with one not voting after adoption of the amendment. HB 2324 would let cities with their own fire codes, through an intergovernmental agreement, enforce those codes on county-owned buildings in city limits, with reporting requirements to the State Fire Marshal; county and fire-management representatives supported the measure as a clarification of jurisdiction, and it passed 6-0 with one not voting. HB 2439 would exempt single-user public or semi-public cold plunges from ADEQ pool rules, but the committee adopted an amendment removing ADEQ rulemaking authority; supporters said the bill would reduce confusion and regulatory burden, while one senator opposed it over public-health concerns, and it passed 4-2 with one not voting. HB 2457 would allow utilities to build certain co-located power plants without a certificate of environmental compatibility after notice and a public comment session, which opponents said would reduce public review and transparency for power plant siting, while supporters said it would streamline power development; it passed 4-2 with one not voting. Finally, HB 2953 would cap certain nondisciplinary and disciplinary civil penalties imposed by the State Board of Pharmacy at $25,000 in specified circumstances; a supporter said it matched limits used elsewhere and gave the board authority to use nondisciplinary actions, and it passed 6-0 with one not voting. The committee then adjourned.